Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2026
Reporting Period: Single event date (March 10, 2026)
The filing discloses a Regulation FD event where the Company posted an updated investor slide presentation on its website. This presentation is intended for use in meetings with investors and analysts.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely to disclose the availability of an updated investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The only material event is the release of new non-financial information via an investor presentation.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to use the attached presentation (Exhibit 99.1) in various meetings with investors and analysts.
- Outlook: The presentation may be amended or updated at any time through future filings.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the attached Exhibit 99.1 (Investor Presentation dated March 2026) for specific operational updates or strategic shifts.
- Confirm whether the presentation contains forward-looking statements that differ from previous guidance.
- Check subsequent filings for any amendments to the presentation referenced in this 8-K.